Back to top

Image: Bigstock

BRO Lags Industry, Trades at a Discount: Time to Hold or Exit?

Read MoreHide Full Article

Key Takeaways

  • BRO's Q3 revenues rose 7.4% to $1.7 billion, supported by acquisitions and diversified operations.
  • BRO up its 2026 Accession synergy estimate to $50 million and its 2028 annualized target to $175 million.
  • BRO faces 15-35% property rate down, lower contingent commissions and elevated acquisition integration costs.

Shares of Brown & Brown, Inc. (BRO - Free Report) have plunged 7.5% in the past year against the industry’s 1% growth.

Soft organic growth, moderating property rates, elevated costs and acquisition-related debt are weighing on the stock. Despite these factors, the company's strong client retention, new business generation and acquisitions remain intact, while a recovery depends on improving earnings growth, stronger insurance market conditions and margin stabilization.

Shares of other insurance brokers like Aon plc (AON - Free Report) have declined 3.4%, while Arthur J. Gallagher & Co. (AJG - Free Report) and Willis Towers Watson Public Limited Company (WTW - Free Report) have gained 13.5% and 4.8%, respectively, over the past year.

1-Year Price Performance - BRO, AON, AJG, WTW & Industry

Zacks Investment Research

Image Source: Zacks Investment Research

BRO’s Valuation

Shares of Brown & Brown are trading at a discount compared with the industry. Its forward 12-month price-to-earnings multiple of 15.34X is lower than the industry average of 16.93X.

Zacks Investment Research

Image Source: Zacks Investment Research

Shares of other insurance brokers like AON, AJG and WTW are also trading at a discount.

BRO’s Average Target Price Suggests Upside

Based on short-term price targets offered by 18 analysts, the Zacks average price target is $75.22 per share. The average suggests a potential 4.1% upside from the last closing price.

Zacks Investment Research
Image Source: Zacks Investment Research

BRO’s Growth Projection

The Zacks Consensus Estimate for Brown & Brown’s 2026 earnings per share (EPS) indicates a year-over-year increase of 4.2%. The consensus estimate for revenues is pegged at $6.93 billion, implying a year-over-year improvement of 17.4%. The consensus estimate for 2027 EPS and revenues indicates increases of 8% and 4%, respectively, from the corresponding 2026 estimates.

Earnings have grown 19.2% over the past five years, better than the industry average of 13.9%. The expected long-term earnings growth rate is 7%.

Factors That Benefit BRO

Brown & Brown's revenue growth is supported by its diversified insurance distribution businesses, acquisition contributions and continued demand for specialized insurance services. Total revenues increased 7.4% year over year to $1.7 billion in the third quarter of 2026. Organic revenue growth was 1.2% or 1.5% including contingent commissions. Retail delivered 2.6% organic growth, supported by new business wins and strength in employee benefits and bond practices.

Strategic acquisitions continue to strengthen BRO's product portfolio, expand its distribution network and support earnings growth. Accession generated approximately $1.7 billion in revenues during its first full year following the acquisition. The company raised its expected 2026 EBITDAC synergies to approximately $50 million compared with the earlier estimate of $30-$40 million. It also increased its target for annualized net synergies by the end of 2028 to $175 million from $150 million, reflecting progress in integration, operating efficiencies and carrier relationships.

Its diversified Retail and Specialty Distribution businesses provide exposure to multiple insurance markets. Management expects organic growth to improve in 2027, projecting growth of 2-4% in Retail and 1-3% in Specialty Distribution. Demand for casualty, professional liability and public entity insurance, along with rising healthcare costs and the need for employee-benefits advisory services, should support business opportunities.

Artificial intelligence and technology investments could provide an additional long-term growth catalyst. Through partnerships with Anthropic, McKinsey and Accenture, BRO is accelerating AI adoption across prospecting, insurance submissions, claims analysis and data extraction.  Its COMPASS platform combines AI capabilities with proprietary data and analytics to support risk-management decisions. These initiatives could improve employee productivity, customer service and operating efficiency.

BRO also benefits from strong cash generation and shareholder-friendly capital allocation. Operating cash flow increased 13% year over year to approximately $1.1 billion in the first nine months of 2026. The company repurchased $750 million of shares during the period, including $250 million in the third quarter. It also raised its annual dividend by 9%, marking its 33rd consecutive year of dividend increases. Strong cash generation provides flexibility to invest in revenue-producing employees, technology, debt reduction and selective acquisitions, supporting long-term growth and shareholder returns.

Risks for BRO

Declining rates in catastrophe-exposed property lines, ranging from 15-35%, could weigh on commission growth and revenues from specialty insurance placements. Increased competition from admitted carriers entering the E&S market could further intensify pricing pressure and limit organic growth in Specialty Distribution.

Specialty Distribution contingent commissions are expected to decline $14-$16 million year over year in the fourth quarter of 2026, potentially weighing on revenues and profitability. Additionally, Accession integration costs of $250-$300 million over three years, along with approximately $90 million in additional expenses, could pressure near-term earnings.

Conclusion

BRO’s commission growth, new business, strong retention, strategic acquisitions, diversified brokerage platform and balanced capital deployment position the company well for growth. Its strong cash flow, AI and technology investments, dividend history, favorable estimates and cheap valuation are other positives. However, pricing pressure, competition and integration costs remain risks. Therefore, it is wise to adopt a wait-and-see approach on this Zacks Rank #3 (Hold) stock. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Published in